Stock ANIK ANIKA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
25.57 USD -0.04% Intraday chart for Anika Therapeutics, Inc. -1.04% +12.84%
Mar. 14 Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating MT
Mar. 13 Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
GL
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GL
Anika: Q4 Earnings Snapshot
AQ
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
AQ
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
GL
Anika Highlights Its Recently Launched IntegrityTM Implant System and RevoMotionTM Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products during the 2024 AAOS Annual Meeting
AQ
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
GL
Anika Announces First Surgeries Performed using the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
AQ
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
GL
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
AQ
Anika to Participate in Upcoming Investor Conferences
GL
Anika: Q3 Earnings Snapshot
AQ
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
AQ
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
GL
Anika Announces the Full Market Release of the RevoMotion Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit, Evolving Technologies Annual Meeting
AQ
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
GL
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
AQ
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANIK Stock
  4. News Anika Therapeutics, Inc.
  5. Press Releases